Did Outcomes From Accepted Donor Lungs Establish Safety for Every Substance-Exposed Organ?
A study of lung transplants can describe outcomes among organs that a transplant program accepted without establishing the safety of every organ it might have rejected. Li and colleagues reviewed 473 adults who received double lung transplants in Edmonton between 2004 and 2016. Of these recipients, 186 received lungs from donors with a recorded history of at least one of the substances evaluated.
What the overall result covered
The investigators examined death or retransplantation and several forms of graft dysfunction. A broad history of donor substance use was not associated with worse outcomes overall in this cohort. That finding describes accepted donor lungs in this program; it is not a comparison that includes every potential donor assessed for transplantation.
The distinction matters because an organ accepted after evaluation can differ from one declined because of disease, injury or other concerns. The observed outcomes cannot show what would have happened had all rejected lungs also been transplanted.
The categories did not all tell the same story
Heavy donor cigarette smoking was associated with greater risk of death or retransplantation, severe primary graft dysfunction and baseline lung allograft dysfunction. The reported hazard ratio for death or retransplantation was 1.47. A small donor crack-cocaine subgroup, involving 24 recipients, also showed worse survival, with a hazard ratio of 2.16 and a reported 95% confidence interval of 1.16 to 3.66.
These were observational associations. They do not establish that a particular exposure alone caused a recipient’s outcome. Conversely, an overall result for a combined substance-use category should not erase the agent-specific findings.
What a recorded history does not establish
Donor exposure information came from surrogate histories obtained during organ procurement. A history is not an analytically measured concentration at transplantation, and the study does not supply an individual dose threshold for graft injury. Some exposure groups were too small for separate analysis.
The supported conclusion is limited to outcomes in this selected, single-center transplant population and its recorded exposure groups. The paper informs interpretation of donor history; it does not replace evaluation of an individual organ or prove that every substance-exposed donor carries the same risk.
Source: Li D, Weinkauf J, Hirji A, et al. Lung Transplantation From Donors With a History of Substance Use. Clinical Transplantation. 2025;39:e70162. doi:10.1111/ctr.70162.



